HomeOCUL • NASDAQ
add
Ocular Therapeutix Inc
Previous close
$8.46
Day range
$8.50 - $9.04
Year range
$4.79 - $11.77
Market cap
1.44B USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 10.70M | -27.59% |
Operating expense | 30.50M | 25.34% |
Net income | -64.05M | 1.23% |
Net profit margin | -598.74 | -36.41% |
Earnings per share | -0.37 | -55.17% |
EBITDA | -62.94M | -105.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 349.68M | -27.59% |
Total assets | 405.92M | -24.68% |
Total liabilities | 139.99M | 6.89% |
Total equity | 265.93M | — |
Shares outstanding | 159.30M | — |
Price to book | 5.07 | — |
Return on assets | -37.00% | — |
Return on capital | -43.58% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -64.05M | 1.23% |
Cash from operations | -44.67M | -31.82% |
Cash from investing | -1.93M | -658.04% |
Cash from financing | 4.18M | -98.70% |
Net change in cash | -42.42M | -114.78% |
Free cash flow | -25.09M | -1.52% |
About
CEO
Founded
2006
Headquarters
Website
Employees
274
